- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER-2 Positive Metastatic Breast Cancer
Total 2526 results
-
Gilead SciencesTerminatedAdvanced Estrogen Receptor Positive HER2- Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
University Hospitals Bristol and Weston NHS Foundation...RecruitingHER2 Negative Metastatic Breast CancerUnited Kingdom
-
Polaris GroupCompletedHER2 Negative Metastatic Breast CancerUnited States
-
Dr Rajendra A. BadweTata Memorial HospitalRecruitingHER2 Positive Breast Cancer | Carcinoma Breast Stage IIndia
-
University of Wisconsin, MadisonRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-negative Breast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedEstrogen-receptor Positive Invasive Metastatic Breast CancerUnited States
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Ruijin HospitalRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterIncyte CorporationWithdrawnBreast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | HER2-positive Breast Cancer
-
Novartis PharmaceuticalsTerminatedMetastatic Breast Cancer | HER2+ Breast CancerBelgium, France, Spain, United States, United Kingdom, Italy
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Breast Neoplasms | Advanced Breast Cancer | Breast Neoplasm Female | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor-positive Breast CancerGermany
-
Institut de cancérologie Strasbourg EuropeRecruiting
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Novartis PharmaceuticalsBreast International Group; German Breast Group; SOLTI Breast Cancer Research...CompletedHER2-positive Newly Diagnosed, Primary Breast CancerAustria, Spain, Australia, Germany
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
M.D. Anderson Cancer CenterZymeworks BC Inc.Active, not recruitingBreast Cancer | HER2-positiveUnited States
-
The Netherlands Cancer InstituteRoche Pharma AG; Borstkanker Onderzoek GroepActive, not recruitingBreast Cancer | HER2 PositiveNetherlands
-
The Netherlands Cancer InstituteCompletedBreast Cancer | HER2 PositiveNetherlands
-
iOMEDICO AGAmgen; Arbeitsgemeinschaft fur Internistische OnkologieWithdrawnAdvanced Breast Cancer | HER2-positive Breast CancerGermany
-
Novartis PharmaceuticalsCompletedMetastatic Colorectal Cancer | Gastric Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Gastroesophageal Junction Cancer | Recurrent Glioblastoma Multiforme | Advanced Pancreatic Adenocarcinoma | Safety | Triple Negative Metastatic Breast Cancer | Dose Escalation | Preliminary Efficacy | Hormone Receptor...Canada, United Kingdom, Spain, Germany, Italy, Belgium, Australia, United States
-
University of MiamiNational Cancer Institute (NCI)Not yet recruitingAdvanced Breast Cancer | HER2-positive Breast CancerUnited States
-
SOLTI Breast Cancer Research GroupRecruitingBreast Cancer | HER2-negative Breast Cancer | Hormone Receptor Positive Tumor | Premenopausal Breast CancerSpain
-
Yongsheng WangJiangsu HengRui Medicine Co., Ltd.RecruitingLocally Advanced Breast Cancer | Hormone Receptor Positive,HER2-negative Breast CancerChina
-
Bavarian NordicActive, not recruitingChordoma | HER2-positive Breast Cancer | HER2-positive Gastric/Gastroesophageal Junction CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedGIST Metastatic Cancer | Breast Metastatic Cancer | Kidney Metastatic Cancer | Colon Metastatic Cancer | Rectal Metastatic CancerFrance
-
Loyola UniversityCompletedMetastatic Breast Cancer | Estrogen Receptor Positive | Adult WomenUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.RecruitingEarly-stage Breast Cancer | Breast Cancer Invasive | HER2 Low Breast Carcinoma | Hormone-receptor-positive Breast CancerChina
-
Peking UniversityRecruitingHER2-positive Breast Cancer | Triple-negative Breast CancerChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer | Neoadjuvant Therapy | Hormone Receptor-positive Breast Cancer | HER2-low-expressing Breast CancerChina
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, Hungary, Indi...
-
Cancer Trials IrelandCompletedHER2 Positive Breast CancerIreland
-
Taiwan Epidemiology AssociationUnknown
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
Institut fuer FrauengesundheitNovartis Pharmaceuticals; AGO Breast Study Group e.V.RecruitingBreast Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerGermany
-
Olema Pharmaceuticals, Inc.Active, not recruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States, Australia
-
National Cancer Institute (NCI)WithdrawnEstrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Filipa Lynce, MDAstraZeneca; Daiichi Sankyo, Inc.RecruitingBreast Cancer | HER2-positive Breast Cancer | Invasive Breast Cancer | Inflammatory Breast Cancer Stage III | HER2 Low Breast AdenocarcinomaUnited States
-
Hunan Cancer HospitalCompletedBreast Neoplasms | HER2-positive Breast CancerChina
-
The Christie NHS Foundation TrustSahlgrenska University Hospital, SwedenActive, not recruitingBreast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited Kingdom, Sweden
-
Fundacion CRIS de Investigación para Vencer el...Bayer; Pfizer; Apices Soluciones S.L.CompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer MetastaticSpain
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | HER2-negative Breast Cancer | Hormone Receptor Positive TumorChina
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States